
pmid: 15469794
handle: 2066/184563 , 2066/59008
Item does not contain fulltext
01 oktober 2004
UMCN 2.1: Heart, lung and circulation, Risk Factors, Practice Guidelines as Topic, Humans, NCEBP 14: Cardiovascular diseases, Risk Assessment, Platelet Aggregation Inhibitors, Randomized Controlled Trials as Topic
UMCN 2.1: Heart, lung and circulation, Risk Factors, Practice Guidelines as Topic, Humans, NCEBP 14: Cardiovascular diseases, Risk Assessment, Platelet Aggregation Inhibitors, Randomized Controlled Trials as Topic
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 34 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
